Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
Clinical trial NCT02794857 · COMPLETED
Trial details
- NCT number
- NCT02794857
- Sponsor
- Neuraltus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2017-12-12
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.